tiprankstipranks

Jay Moyes Insider Profile

11 Followers
Jay Moyes, Director at BioCardia, holds 58.32K shares in Puma Biotechnology (Ticker: PBYI), holds 4.00K shares in Sintx Technologies (Ticker: SINT), holds 35.63K shares in Sera Prognostics (Ticker: SERA).
tipranks
Jay Moyes

Jay Moyes
BioCardia (BCDA)
Director

Ranked #55,698 out of 108,437 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

-0.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$718K
70.73%
11.34%
9.97%
7.01%
0.95% Others
A breakdown of Jay Moyes's holdings

Insider Roles

Puma Biotechnology
(PBYI)
Director
Myriad Genetics
(MYGN)
CFO
Sera Prognostics
(SERA)
CFO
BioCardia
(BCDA)
Director
+2 other positions
Roles that Jay Moyes holds in companies

Most Profitable Insider Trade

Stock:
Puma Biotechnology
(PBYI)
Rating:Informative Sell
Date:Jun 11, 2021 - Jun 11, 2022
Return:+77.10%
The most profitable trade made by Jay Moyes

Jay Moyes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BioCardia
Apr 07, 2021
Director
Uninformative Buy
$50.36K
Sera Prognostics
Mar 07, 2023
CFO
Uninformative Buy
$71.62K
Puma Biotechnology
Jun 15, 2026
Director
Uninformative Buy
$507.98K
Achieve Life Sciences
Director
$0.00
Myriad Genetics
CFO
$81.41K
Sintx Technologies
Feb 25, 2026
Director
Informative Buy
2.91K
$6.84K
OSIR
Osiris Therapeutics Inc
Feb 07, 2014
Uninformative Buy
74.65K
$408.29K
List of latest transactions for each holding click on a transaction to see Jay Moyes's performance on stock

Jay Moyes insider profile FAQ

What is the percentage of profitable transactions made by Jay Moyes?
The percentage of profitable transactions made by Jay Moyes is 40%.
    What is the average return per transaction made by Jay Moyes?
    The average return per transaction made by Jay Moyes is -0.80%.
      What stocks does Jay Moyes hold?
      Jay Moyes holds: BCDA, SERA, PBYI, ACHV, MYGN, SINT, OSIR stocks.
        What was Jay Moyes’s latest transaction?
        Jay Moyes latest transaction was an Uninformative Buy of ―.
          What was Jay Moyes's most profitable transaction?
          Jay Moyes’s most profitable transaction was an Informative Sell of PBYI stock on June 11, 2021. The return on the trade was 77.10%.
            What is Jay Moyes's role in BioCardia?
            Jay Moyes's role in BioCardia is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.